You are here
WCM Chief Highlights Cancer Research During 'Stand Up to Cancer' Event
September 14, 2016
Dr. David Nanus, the chief of Hematology and Medical Oncology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center appeared briefly during the annual Stand Up to Cancer broadcast on Sept. 9, a star-studded event that received more than $111 million in pledged donations to help fund research that leads to new therapies and saves lives.
Dr. Nanus, along with Dr. Naiyer Rizvi from Columbia University, explained how their teams — in partnership with NewYork-Presbyterian Hospital — are using precision medicine and immunotherapy to treat cancer.
Weill Cornell Medicine is at the forefront of studying these cutting-edge approaches to cancer care, which have shown promising results in patients enrolled in clinical trials. CHECK.
At the Englander Institute for Precision Medicine, researchers are exploring ways to make treatments more effective while minimizing side effects by tailoring treatments to each patient's genetic profile and medical history.
Meanwhile, scientists at the Sandra and Edward Meyer Cancer Center are also exploring immunotherapy, which harnesses the power of a patient's immune system to destroy cancer cells.
Watch the video above to learn more about our efforts to develop new and better therapies against cancer.